dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:17:27Z
dc.date.available2014-05-27T11:17:27Z
dc.date.created2014-05-27T11:17:27Z
dc.date.issued1992-01-06
dc.identifierNeuroscience Letters. Clare: Elsevier Sci Ireland Ltd, v. 134, n. 2, p. 212-214, 1992.
dc.identifier0304-3940
dc.identifierhttp://hdl.handle.net/11449/130655
dc.identifier10.1016/0304-3940(92)90519-D
dc.identifierWOS:A1992HB71300016
dc.identifier2-s2.0-0026527715
dc.identifier6551236936295697
dc.description.abstractIn the present study we investigated the effects of central (i.c.v.) and subcutaneous (s.c.) injections of a 2 μg dose of lisinopryl, an inhibitor of angiotensin I(ANGI)-converting enzyme (CE), on water intake. I.c.v. but not s.c. injection of lisinopryl abolished drinking in response to s.c. isoprenaline (100 μg/kg) and significantly reduced drinking in response to 24 h water deprivation or s.c. polyethylene glycol (30% w/v, 10 ml/kg). Lisinopryl had no effect on water intake induced by cellular dehydration (s.c. injection of hypertonic saline (2 M NaCl)). These results are consistent with the hypothesis that lisinopryl acts as a CE blocking agent in the brain. The thirst challenge induced by hypotension using isoprenaline acts primarily by generating ANGII systemically and centrally. The other thirst challenges such as cellular dehydration are independent of the ANGII in the brain. This conclusion was made possible by utilizing a new CE blocking agent at a smaller dose than normally used for other ANG I-CE inhibitors. © 1992.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationNeuroscience Letters
dc.relation2.159
dc.relation0,946
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectAngiotensin
dc.subjectLateral ventricle
dc.subjectLisinopryl
dc.subjectWater intake
dc.subjectLisinopril
dc.subjectAnimal experiment
dc.subjectFluid intake
dc.subjectIntracerebroventricular drug administration
dc.subjectMale
dc.subjectNonhuman
dc.subjectPriority journal
dc.subjectRat
dc.subjectSubcutaneous drug administration
dc.subjectAngiotensin-Converting Enzyme Inhibitors
dc.subjectAnimal
dc.subjectCerebral Ventricles
dc.subjectDrinking Behavior
dc.subjectEnalapril
dc.subjectInjections, Intraventricular
dc.subjectInjections, Subcutaneous
dc.subjectIsoproterenol
dc.subjectLisinopril
dc.subjectMale
dc.subjectRats
dc.subjectReference Values
dc.subjectSaline Solution, Hypertonic
dc.subjectSupport, Non-U.S. Gov't
dc.subjectTime Factors
dc.titleAlterations in the water intake caused by central inhibition of angiotensin-converting enzyme in the rat
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución